Form 4 for IRMD IRADIMED CORP

Accepted 2026-06-04 16:21:52 ET · period of report 2026-06-04 · accession 0001950129-26-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-06-04 16:21	2026-06-04	IRMD	Scharen-Guivel Hilda Frederique	Dir	S - Sale	$95.00	-3,000	5,598	-35%	-$285.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-04	S	D	1,766	$95.00	6,832	D	—	—	(F1) This transaction was executed at $95.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) The shares reported as beneficially owned following the reported transaction consist of shares acquired upon the vesting and settlement of restricted stock units granted in connection with the reporting person's service as a director. Such shares were acquired in multiple vesting transactions occurring on various dates.
2	Common	Common Stock	2026-06-04	S	D	1,234	$95.00	5,598	D	—	—	(F1) This transaction was executed at $95.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) The shares reported as beneficially owned following the reported transaction consist of shares acquired upon the vesting and settlement of restricted stock units granted in connection with the reporting person's service as a director. Such shares were acquired in multiple vesting transactions occurring on various dates.